The mixed mode chromatography resin market is projected to experience substantial growth, with a remarkable compound annual growth rate (CAGR) of 15.7% throughout the forecast period spanning from 2022 to 2032. It is anticipated that the market share of mixed mode chromatography resin will witness a significant surge, estimated to reach a value of nearly US$ 428 Million by 2032. This substantial growth is expected as the market expands from its recorded value of US$ 91 Million in 2021.
Mixed mode chromatography resin is a vital component in the field of biopharmaceuticals, biotechnology, and the life sciences industry. It plays a crucial role in the purification and separation of biomolecules, such as proteins and antibodies. The mixed mode chromatography resin market has witnessed substantial growth over the years, driven by the increasing demand for advanced purification techniques and the growing biopharmaceutical industry.
Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=7451
The market is characterized by its versatility, as mixed mode chromatography resin offers a wide range of applications, from separating proteins to purifying antibodies. This adaptability has led to a surge in its adoption across various industries, including pharmaceuticals, food and beverages, and research institutions.
Market Opportunity:
One of the primary opportunities in the mixed mode chromatography resin market is the rising demand for monoclonal antibodies and other biopharmaceutical products. With an aging global population and a growing prevalence of chronic diseases, the need for innovative therapies has never been higher. Mixed mode chromatography resin is a key component in the development and production of these life-saving biotherapeutics, creating a substantial growth opportunity.
Additionally, the adoption of mixed mode chromatography resin is also increasing in the food and beverage industry. Companies are using this technology for the purification of enzymes, flavors, and other bioactive compounds, enhancing product quality and consistency.
Market Challenges:
Despite the promising outlook, the mixed mode chromatography resin market is not without its challenges. One of the major hurdles is the high cost associated with these resins. The production and purification processes can be complex and costly, making it essential for manufacturers to find ways to reduce production expenses and offer cost-effective solutions.
Another challenge is the lack of skilled professionals who can effectively operate and maintain mixed mode chromatography systems. Addressing this issue will require significant investment in training and education within the industry.
Key Players:
- Bio-Rad Laboratories, Inc.
- GE Healthcare
- Purolite Corporation
- Danaher Corporation
- Avantor
- JSR Micro Inc.
- Kaneka Corporation
- Thermo Fisher Scientific
- Sepragen Corporation
- Merck among others.
Competitive Landscape:
In January 2017, Kaneka Corporation introduced a new iteration of “KANEKA KanCapA 3G,” a revolutionary protein resin chromatography utilized in immune response therapy. This advanced version boasts a remarkable 50 percent higher binding rate compared to its conventional counterparts, aiming to reduce expenses associated with antibody treatment processes and enhance overall productivity. Consequently, the implementation of KANEKA KanCapA 3G is anticipated to significantly improve processing time, minimize pollution, and optimize operational efficiencies.
Celsee, Inc., a company specializing in the provision of tools and consumables for the separation, identification, and characterization of individual cells, was acquired by Bio-Rad Laboratories, Inc. in April 2020. With its state-of-the-art products and cutting-edge technology, Celsee aims to expand Bio-Rad’s reach into the rapidly growing fields of precision medicine and single-cell analysis. These innovative solutions offer a deeper understanding of diseases, diagnoses, and therapies, ultimately paving the way for improved medical outcomes.
Key Segments
- By Type :
- Ion Exchange Hydrophobic Type
- Hydroxyapatite Type
- Others
- By Application :
- Antibodies Production
- Vaccine Production
- Non-antibody Proteins
- Antibody-drug Conjugate
- Separation of Low Molecular Weight Impurities
- Others
- By Region :
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa (MEA)
Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=7451
About Fact.MR :
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client’s satisfaction.
Contact:
US Sales Office
11140 Rockville Pike
Suite 400 Rockville, MD 20852
United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: [email protected]
Follow Us: LinkedIn | Twitter | YouTube